Solid Biosciences (SLDB) Cash from Operations Growth (1y) (2018 - 2026)
Solid Biosciences (SLDB) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Solid Biosciences |
789.54 Mn |
408.86 Mn |
- |
-48.29% |
| Date | Value |
|---|
| Mar 31, 2026 |
-48.29% |
| Dec 31, 2025 |
-80.65% |
| Sep 30, 2025 |
-41.18% |
| Jun 30, 2025 |
-74.28% |
| Mar 31, 2025 |
-26.43% |
| Dec 31, 2024 |
-42.37% |
| Sep 30, 2024 |
-32.47% |
| Jun 30, 2024 |
21.84% |
| Mar 31, 2024 |
10.01% |
| Dec 31, 2023 |
39.61% |
| Sep 30, 2023 |
12.39% |
| Jun 30, 2023 |
-72.98% |
| Mar 31, 2023 |
-2.96% |
| Dec 31, 2022 |
-65.18% |
| Sep 30, 2022 |
-10.88% |
| Jun 30, 2022 |
7.15% |
| Mar 31, 2022 |
-27.26% |
| Dec 31, 2021 |
-1,697.09% |
| Sep 30, 2021 |
-18.38% |
| Jun 30, 2021 |
-30.85% |
